Medications

Chelation therapy does not improve outcomes after heart attack

People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke ...

Medications

Plozasiran reduces triglyceride levels by 74% at 24 weeks

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing ...

Medical economics

Holdout states consider expanding Medicaid—with work requirements

In Humphreys County, Mississippi—about 70 miles north of the state capital, in the heart of the fertile Delta region—a third of the residents live in poverty. In Belzoni, the county seat, there are just a handful of health ...

Overweight & Obesity

BRD7 research points to alternative insulin signaling pathway

Bromodomain-containing protein 7 (BRD7) was initially identified as a tumor suppressor, but further research has shown it has a broader role in other cellular processes, including the remodeling of chromosomes and cell cycle ...

page 6 from 6